Ogrodnik, Mikolaj
Miwa, Satomi
Tchkonia, Tamar
Tiniakos, Dina
Wilson, Caroline L.
Lahat, Albert
Day, Christoper P.
Burt, Alastair
Palmer, Allyson http://orcid.org/0000-0001-7505-3455
Anstee, Quentin M. http://orcid.org/0000-0002-9518-0088
Grellscheid, Sushma Nagaraja
Hoeijmakers, Jan H J.
Barnhoorn, Sander
Mann, Derek A.
Bird, Thomas G.
Vermeij, Wilbert P.
Kirkland, James L.
Passos, João F.
von Zglinicki, Thomas
Jurk, Diana http://orcid.org/0000-0003-4486-0857
Article History
Received: 24 June 2016
Accepted: 20 April 2017
First Online: 13 June 2017
Competing interests
: Patents on INK-ATTAC mice and senolytic drugs are held by Mayo Clinic and licensed to Unity Biotechnology. J.L.K., A.P. and T.T. may gain financially from these patents and licenses. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic conflict of interest policies. The remaining authors declare no competing financial interests.